Skip to main content

Kodiak Sciences Inc.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (unaudited)

(in thousands, except share and per share amounts)

September 30,2025December 31,2024
Assets
Current assets:
Cash and cash equivalents$72,038$168,074
Prepaid expenses and other current assets3,6903,862
Total current assets75,728171,936
Restricted cash6,1846,184
Property and equipment, net88,905102,222
Operating lease right-of-use asset38,57746,508
Other assets8,6758,728
Total assets$218,069$335,578
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$10,371$3,915
Accrued and other current liabilities20,30511,030
Operating lease liability11,75310,628
Total current liabilities42,42925,573
Long-term operating lease liability50,44859,717
Liability related to sale of future royalties100,000100,000
Long-term deposit1,500—
Total liabilities194,377185,290
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized; none issued——
Common stock, $0.0001 par value – 490,000,000 shares authorized; 52,998,561 and 52,726,916 shares issued and outstanding, respectively55
Additional paid-in capital1,525,6561,479,021
Accumulated deficit(1,501,969)(1,328,738)
Total stockholders’ equity23,692150,288
Total liabilities and stockholders’ equity$218,069$335,578
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.